
February 2012
Advertisement
Advertisement
Trending on HCPLive
1
Q&A: Mucus Plugging, Multimorbidity, and GOLD 2027, With Gerard Criner, MD
2
Omalizumab Biosimilar CT-P39: Quality of Life Gains Precede CSU Control
3
Enlicitide Lowers LDL-C Consistently Across PREVENT CVD Risk Categories
4
Diabetes Dialogue: Retatrutide Tops Semaglutide on A1C, Weight in T2D
5